Venus Concept (VERO) Registration Filing summary

Company overview and business model

• Develops and commercializes minimally invasive and non-invasive medical aesthetic and hair restoration technologies and services, targeting both traditional and non-traditional medical markets.

• Revenue streams include product sales (systems, consumables, disposables), service contracts, and a subscription-based model with recurring payments.

• Holds regulatory clearance for twelve technology platforms, including ARTAS and NeoGraft, and operates in over 60 countries with direct presence in 12 international markets.

• Strategic shift underway to reduce reliance on subscription sales in the U.S. to improve cash generation and reduce credit risk.

Financial performance and metrics

• Maximum aggregate offering price for securities under this registration is $30,368,647.94.

• Common stock last reported sale price was $0.46 per share on October 21, 2024, on Nasdaq Capital Market.

Use of proceeds and capital allocation

• Net proceeds from securities sales will be allocated as described in the applicable prospectus supplement for each offering.